RSEBX | RTXCX | RSEBX / RTXCX | |
Total Expense Ratio | 1.45 | 2.08 | 70% |
Annual Report Gross Expense Ratio | 1.45 | 2.17 | 67% |
Fund Existence | 11 years | 6 years | - |
Gain YTD | -1.922 | 1.252 | -154% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 71.8B | 1.06B | 6,806% |
Annual Yield % from dividends | 0.22 | 1.21 | 18% |
Returns for 1 year | -0.81 | 1.75 | -46% |
Returns for 3 years | 17.03 | 3.34 | 510% |
Returns for 5 years | 21.22 | 50.03 | 42% |
Returns for 10 years | 29.01 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VPL | 76.58 | 0.43 | +0.56% |
Vanguard FTSE Pacific ETF | |||
FNDB | 22.61 | 0.01 | +0.04% |
Schwab Fundamental U.S. Broad Market ETF | |||
FCAL | 48.19 | 0.01 | +0.02% |
First Trust California Muni Hi Inc ETF | |||
IDNA | 19.16 | -0.43 | -2.19% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
YOLO | 1.80 | -0.06 | -3.23% |
AdvisorShares Pure Cannabis ETF |